Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
Andrew C. Li, Kathleen K. Brown, Mercedes Silvestre et al. · Journal of Clinical Investigation · 2000
The peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor that regulates fat-cell development and glucose homeostasis and is the molecular target of a class of insulin-sensitizing agents used for the management of type 2 diabetes mellitus. PPARgamma is highly expressed in macrophage foam cells of atherosclerotic lesions and has been demonstrated in cultured macrophages to both positively and negatively regulate genes implicated in the development of atherosclerosis. We report here that the PPARgamma-specific agonists rosiglitazone and GW7845 strongly inhibited the development of atherosclerosis in LDL receptor-deficient male mice, despite increased expression of the CD36 scavenger receptor in the arterial wall. The antiatherogenic effect in male mice was correlated with improved insulin sensitivity and decreased tissue expression of TNF-alpha and gelatinase B, indicating both systemic and local actions of PPARgamma. These findings suggest that PPARgamma agonists may exert antiatherogenic effects in diabetic patients and provide impetus for efforts to develop PPARgamma ligands that separate proatherogenic activities from antidiabetic and antiatherogenic activities.
Cited by 833 works. doi:10.1172/jci10370 Open-access PDF
Authors
- Andrew C. Li
- Kathleen K. Brown
- Mercedes Silvestre
- Timothy Mark Willson
- Wulf Palinski
- Christopher K. Glass
References
- Atherosclerosis — An Inflammatory Disease
- Beyond Cholesterol
- The Pathogenesis of Atherosclerosis — An Update
- Diabetes and cardiovascular disease. The Framingham study
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
- Book ReviewAmbulatory Pediatric Care
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
- PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
- Diabetes and Cardiovascular Disease